Featured Articles
-
How Leveraging A Global Network Delivered Big Results
10/30/2020
Mike’s team in Bend, OR was only supposed to optimize the spray drying process for a particular medication while another, much larger, facility would handle the large-scale manufacturing. However, the other facility’s equipment wouldn’t be available in time to meet the client’s aggressive IND filing schedule.
-
The Supply Chain Executive's Perspective On Single-Supplier CDMOs
7/7/2017
A single vendor offers access to a network of experts who can share knowledge about a project as it moves from phase to phase, thus helping to navigate its path toward commercial success.
-
Strategic CDMO: End-To-End Solutions Speed Drug Development
5/17/2016
Patheon's Bill Weiser discusses how a new generation of CDMOs have positioned themselves to provide strategic solutions that not only complement product development but also drive therapies to patients faster.
-
4 Ways To Avoid Failure In Phase III Clinical Manufacturing
Understanding the challenges in the biopharma space is critical, as the planning you do today dictates the options you have later when the costs — and the stakes — get even higher.
-
Saving Development Time With A Single-Vendor Approach
Hear a customer’s perspective on how working with a global network integrated by a dedicated program manager can help you accelerate the drug development process and reach the market sooner.
-
Tufts Study: Single-Source Drug Development, Manufacturing Advantages
A recent study by the Tufts Center for the Study of Drug Development (CSDD) compared cycle times and development economics between multi- and single-source CDMO models.
-
Single-Vendor CDMOs Bring Speed And Cost Savings To The Table
As drug developers face the ever-pressing need to get molecules to market as efficiently as possible, firms large and small are increasingly turning to CDMOs for help.